Viktor Umansky

7.3k total citations · 2 hit papers
94 papers, 5.6k citations indexed

About

Viktor Umansky is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Viktor Umansky has authored 94 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Immunology, 51 papers in Oncology and 31 papers in Molecular Biology. Recurrent topics in Viktor Umansky's work include Immune cells in cancer (50 papers), Immunotherapy and Immune Responses (26 papers) and Cancer Immunotherapy and Biomarkers (23 papers). Viktor Umansky is often cited by papers focused on Immune cells in cancer (50 papers), Immunotherapy and Immune Responses (26 papers) and Cancer Immunotherapy and Biomarkers (23 papers). Viktor Umansky collaborates with scholars based in Germany, United States and Israel. Viktor Umansky's co-authors include Jochen Utikal, Alexandra Sevko, Christoffer Gebhardt, Peter Altevogt, C Blattner, Rebekka Weber, Christopher Groth, Samantha Lasser, Ihor Arkhypov and Xiaoying Hu and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Viktor Umansky

91 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors

2018 406 citations Rebekka Weber, Viktor Fleming et al. Frontiers in Immunology profile →
Myeloid-derived suppressor cells in cancer and cancer therapy

2024 215 citations Samantha Lasser, Feyza Gül Özbay Kurt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Viktor Umansky Germany	42	3.6k	2.8k	1.7k	625	460	94	5.6k
Viktor Umansky Germany	31	4.4k 1.2×	2.9k 1.0×	1.7k 1.0×	605 1.0×	374 0.8×	60	6.3k
Marco Donia Denmark	45	3.8k 1.1×	4.3k 1.5×	2.0k 1.2×	490 0.8×	520 1.1×	195	6.7k
Andrea Schietinger United States	25	3.5k 1.0×	3.1k 1.1×	1.2k 0.7×	336 0.5×	305 0.7×	41	5.1k
Wojciech Szeliga United States	19	4.0k 1.1×	3.0k 1.1×	1.5k 0.8×	564 0.9×	367 0.8×	26	5.7k
Damya Laoui Belgium	31	3.6k 1.0×	2.3k 0.8×	1.9k 1.1×	858 1.4×	406 0.9×	60	5.5k
Susanna Mandruzzato Italy	36	6.1k 1.7×	3.2k 1.1×	2.0k 1.1×	693 1.1×	403 0.9×	77	7.8k
Marc Schmitz Germany	46	3.2k 0.9×	2.8k 1.0×	2.0k 1.2×	440 0.7×	530 1.2×	173	6.4k
Linda A. Snyder United States	25	2.7k 0.8×	2.4k 0.9×	1.5k 0.8×	614 1.0×	564 1.2×	46	4.6k
Sabina Sangaletti Italy	33	2.4k 0.7×	1.6k 0.6×	1.3k 0.8×	531 0.8×	473 1.0×	81	4.4k
Stefanie K. Wculek Spain	18	2.8k 0.8×	1.8k 0.6×	1.6k 0.9×	475 0.8×	406 0.9×	21	4.7k

Countries citing papers authored by Viktor Umansky

Since Specialization

Citations

This map shows the geographic impact of Viktor Umansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Umansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Umansky more than expected).

Fields of papers citing papers by Viktor Umansky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktor Umansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Umansky. The network helps show where Viktor Umansky may publish in the future.

Co-authorship network of co-authors of Viktor Umansky

This figure shows the co-authorship network connecting the top 25 collaborators of Viktor Umansky. A scholar is included among the top collaborators of Viktor Umansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktor Umansky. Viktor Umansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Ke, Yuxin Zhang, Daniel Novak, et al.. (2025). Direct transdifferentiation of tumorigenic melanoma cells induces tumor cell reversion. Cell Death and Disease. 16(1). 563–563.

Umansky, Viktor. (2025). MDSCs as major inducers of immunosuppression in melanoma. 8(CITIM). 24–24.

Kurt, Feyza Gül Özbay, Carolina De La Torre, Volker Ast, et al.. (2024). S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling. Journal for ImmunoTherapy of Cancer. 12(9). e009552–e009552. 16 indexed citations

Petrova, Vera, Christopher Groth, Ihor Arkhypov, et al.. (2023). Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients. Frontiers in Immunology. 14. 12 indexed citations

Kurt, Feyza Gül Özbay, Carolina De La Torre, Samantha Lasser, et al.. (2022). STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice. Journal for ImmunoTherapy of Cancer. 10(3). e004384–e004384. 56 indexed citations

Arkhypov, Ihor, Feyza Gül Özbay Kurt, Daniel Novak, et al.. (2022). HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling. Journal for ImmunoTherapy of Cancer. 10(9). e005551–e005551. 32 indexed citations

Sun, Qian, et al.. (2022). ADCK2 Knockdown Affects the Migration of Melanoma Cells via MYL6. Cancers. 14(4). 1071–1071. 15 indexed citations

Groth, Christopher, Ludovica Arpinati, Merav E. Shaul, et al.. (2021). Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression. Cancers. 13(4). 726–726. 24 indexed citations

Weber, Rebekka, Christopher Groth, Samantha Lasser, et al.. (2020). IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy. Cellular Immunology. 359. 104254–104254. 219 indexed citations

10.

Gebhardt, Christoffer, Rebekka Weber, Raphael Reinhard, et al.. (2020). Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study. Cellular Immunology. 360. 104274–104274. 19 indexed citations

11.

Federico, Aniello, Lionel Larribère, Daniel Novak, et al.. (2020). Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma. Molecular Therapy — Oncolytics. 18. 83–99. 26 indexed citations

12.

Fleming, Viktor, Xiaoying Hu, Rebekka Weber, et al.. (2019). Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling. Cancer Research. 79(18). 4715–4728. 110 indexed citations

13.

Kappelmann‐Fenzl, Melanie, Silke Kuphal, Rosemarie Krupar, et al.. (2019). Complex Formation with Monomeric α-Tubulin and Importin 13 Fosters c-Jun Protein Stability and Is Required for c-Jun’s Nuclear Translocation and Activity. Cancers. 11(11). 1806–1806. 6 indexed citations

14.

Blattner, C, Viktor Fleming, Rebekka Weber, et al.. (2018). CCR5+ Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions. Cancer Research. 78(1). 157–167. 151 indexed citations

15.

Yamauchi, Yoshikane, Seyer Safi, C Blattner, et al.. (2018). Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non–Small Cell Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 198(6). 777–787. 131 indexed citations

16.

Utikal, Jochen, et al.. (2018). Opposing roles of eosinophils in cancer. Cancer Immunology Immunotherapy. 68(5). 823–833. 92 indexed citations

17.

Blacher, Eran, Lilach Abramovitz, Anat Klein, et al.. (2016). Incipient Melanoma Brain Metastases Instigate Astrogliosis and Neuroinflammation. Cancer Research. 76(15). 4359–4371. 68 indexed citations

18.

Berraondo, Pedro, Viktor Umansky, & Ignacio Melero. (2012). Changing the Tumor Microenvironment: New Strategies for Immunotherapy. Cancer Research. 72(20). 5159–5164. 21 indexed citations

19.

Michels, Tillmann, Galina V. Shurin, Hiam Naiditch, et al.. (2012). Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cellsin vitroin a TLR4-independent manner. Journal of Immunotoxicology. 9(3). 292–300. 130 indexed citations

20.

Schneider, Thomas, Arne Warth, Philipp A. Schnabel, et al.. (2011). Foxp3+ Regulatory T Cells and Natural Killer Cells Distinctly Infiltrate Primary Tumors and Draining Lymph Nodes in Pulmonary Adenocarcinoma. Journal of Thoracic Oncology. 6(3). 432–438. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact